UPPER GASTROINTESTINAL PERFORATION

UPPER GASTROINTESTINAL PERFORATION was reported 63 times

These drug classes are most commonly taken by patients reporting UPPER GASTROINTESTINAL PERFORATION:

# Drug Count
0 Nonsteroidal Anti-inflammatory Drug [EPC] 17
1 Factor Xa Inhibitor [EPC] 10
2 Microtubule Inhibitor [EPC] 8
3 Platinum-based Drug [EPC] 8
4 Vascular Endothelial Growth Factor Inhibitor [EPC] 5
5 Corticosteroid [EPC] 4
6 Programmed Death Receptor-1 Blocking Antibody [EPC] 4
7 Proton Pump Inhibitor [EPC] 4
8 HER2/neu Receptor Antagonist [EPC] 3
9 Loop Diuretic [EPC] 3
10 Nucleoside Metabolic Inhibitor [EPC] 3
11 Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] 3
12 Interleukin-6 Receptor Antagonist [EPC] 2
13 Aldosterone Antagonist [EPC] 1
14 CD20-directed Cytolytic Antibody [EPC] 1
15 CTLA-4-directed Blocking Antibody [EPC] 1
16 Calcineurin Inhibitor Immunosuppressant [EPC] 1
17 Complement Inhibitor [EPC] 1
18 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1
19 Dihydropyridine Calcium Channel Blocker [EPC] 1
20 Epidermal Growth Factor Receptor Antagonist [EPC] 1
21 Estrogen Receptor Antagonist [EPC] 1
22 Fluoroquinolone Antibacterial [EPC] 1
23 Folate Analog Metabolic Inhibitor [EPC] 1
24 GLP-1 Receptor Agonist [EPC] 1
25 Glycopeptide Antibacterial [EPC] 1
26 Histamine-2 Receptor Antagonist [EPC] 1
27 Integrin Receptor Antagonist [EPC] 1
28 Interleukin-4 Receptor alpha Antagonist [EPC] 1
29 Janus Kinase Inhibitor [EPC] 1
30 Kinase Inhibitor [EPC] 1
31 Nucleoside Analog Antiviral [EPC] 1
32 Oxytocic [EPC] 1
33 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1
34 Phosphodiesterase 5 Inhibitor [EPC] 1
35 Platelet Aggregation Inhibitor [EPC] 1
36 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 1
37 RNA Synthetase Inhibitor Antibacterial [EPC] 1
38 Selective T Cell Costimulation Modulator [EPC] 1
39 Sulfonamide Antimicrobial [EPC] 1
40 Tumor Necrosis Factor Blocker [EPC] 1
41 Xanthine Oxidase Inhibitor [EPC] 1
42 alpha-Adrenergic Blocker [EPC] 1
43 beta-Adrenergic Blocker [EPC] 1